Eton Pharmaceuticals names Danka Radosavljevic chief operating officer

ETON•2026-08-04

Eton Pharmaceuticals appoints new chief operating officer

Eton Pharmaceuticals appointed Danka Radosavljevic as chief operating officer on July 31, 2026.

Radosavljevic previously served as executive vice president, operations, overseeing quality, product development, regulatory, supply chain, information systems.

She has been with the company since 2017.

Sources

Eton Pharmaceuticals names Danka Radosavljevic chief operating officer

Sec

Eton Pharmaceuticals names Danka Radosavljevic chief operating officer

Eton Pharmaceuticals appoints new chief operating officer

Related News

Zebra Technologies gains after annual forecast raise

Albany International Q2 Sales USD 329.482 Million

Cummins Q2 FY26 net income rises to $932 million; revenue climbs 9% to $9.46 billion vs FY25

Sources

Eton Pharmaceuticals names Danka Radosavljevic chief operating officer

ImmunityBio Q2 net product revenue rises 92%

Turning Point Brands Q2 Sales USD 142.96 Million Vs. IBES Estimate USD 129.2 Million